Myelodysplastic syndrome and acute myelogenous leukemia secondary to heart transplantation

Transplantation

Volumn 70, Issue 4, 2000, Pages 688-690

  Huebner, Gerdt ^a,b   Karthaus, Meinolf ^a   Pethig, Klaus ^a   Freund, Mathias ^a   Ganser, Arnold ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Westpfalz Klinikum GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; IDARUBICIN; PREDNISONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER RISK; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT REJECTION; HEART GRAFT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MONOSOMY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REFRACTORY ANEMIA; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0034721329     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200008270-00026     Document Type: Article

References (10)

1. Incidence and treatment of neoplasia after transplantation
2. Leukemia in the immunosuppressed organ recipient
3. Incidence and treatment of cancer in transplant recipients
4. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients
5. Post-transplant acute myeloid leukemia
6. Malignant neoplasms following cardiac transplantation
7. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure
8. Effect of azathioprine on the chromosome complement of human bone marrow cells
9. Acute myeloid leukemia after azathioprine treatment for autoimmune diseases: Association with -7/7q-
10. Therapy-related acute myeloid leukaemia following immunosuppression with azathioprine for polymyositis